1. Home
  2. SNDX vs CRSR Comparison

SNDX vs CRSR Comparison

Compare SNDX & CRSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
  • CRSR
  • Stock Information
  • Founded
  • SNDX 2005
  • CRSR 1994
  • Country
  • SNDX United States
  • CRSR United States
  • Employees
  • SNDX N/A
  • CRSR N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • CRSR Computer Manufacturing
  • Sector
  • SNDX Health Care
  • CRSR Technology
  • Exchange
  • SNDX Nasdaq
  • CRSR Nasdaq
  • Market Cap
  • SNDX 1.2B
  • CRSR 1.1B
  • IPO Year
  • SNDX 2016
  • CRSR 2020
  • Fundamental
  • Price
  • SNDX $13.18
  • CRSR $9.11
  • Analyst Decision
  • SNDX Strong Buy
  • CRSR Buy
  • Analyst Count
  • SNDX 10
  • CRSR 6
  • Target Price
  • SNDX $36.20
  • CRSR $10.17
  • AVG Volume (30 Days)
  • SNDX 1.8M
  • CRSR 873.0K
  • Earning Date
  • SNDX 03-03-2025
  • CRSR 05-06-2025
  • Dividend Yield
  • SNDX N/A
  • CRSR N/A
  • EPS Growth
  • SNDX N/A
  • CRSR N/A
  • EPS
  • SNDX N/A
  • CRSR N/A
  • Revenue
  • SNDX $23,680,000.00
  • CRSR $1,316,379,000.00
  • Revenue This Year
  • SNDX $274.86
  • CRSR $16.15
  • Revenue Next Year
  • SNDX $130.47
  • CRSR $10.40
  • P/E Ratio
  • SNDX N/A
  • CRSR N/A
  • Revenue Growth
  • SNDX N/A
  • CRSR N/A
  • 52 Week Low
  • SNDX $12.06
  • CRSR $5.60
  • 52 Week High
  • SNDX $25.07
  • CRSR $13.02
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 43.83
  • CRSR 34.97
  • Support Level
  • SNDX $12.70
  • CRSR $9.57
  • Resistance Level
  • SNDX $14.29
  • CRSR $10.41
  • Average True Range (ATR)
  • SNDX 0.66
  • CRSR 0.50
  • MACD
  • SNDX 0.03
  • CRSR -0.17
  • Stochastic Oscillator
  • SNDX 45.32
  • CRSR 0.43

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About CRSR Corsair Gaming Inc.

Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.

Share on Social Networks: